MONOCLONAL ANTIBODY 3F8 Uses, Dosage, Side Effects and more
MONOCLONAL ANTIBODY 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment).
| Trade Name | MONOCLONAL ANTIBODY 3F8 |
| Generic | Anti-GD2 monoclonal antibody 3F8 |
| Anti-GD2 monoclonal antibody 3F8 Other Names | MONOCLONAL ANTIBODY 3F8 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
